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Background: White matter lesions (WMLs), asymptomatic lacunar infarcts, brain microb-
leeds (BMBs), and enlarged perivascular spaces (EPVS) have been identified as silent
lesions due to cerebral small vessel disease (cSVD). All these markers have been indi-
vidually linked to cognitive functioning, but are also strongly correlated with each other.
The combined effect of these markers on cognitive function has never been studied and
would possibly provide more useful information on the effect on cognitive function.
Methods: Brain MRI and extensive neuropsychological assessment were performed in
189 patients at risk for cSVD (112 hypertensive patients and 77 first-ever lacunar stroke
patients). We rated the presence of any asymptomatic lacunar infarct, extensive WMLs,
any deep BMB, and moderate to extensive EPVS in the basal ganglia.The presence of each
marker was summed to an ordinal score between 0 and 4. Associations with domains of
cognitive function (memory, executive function, information processing speed, and overall
cognition) were analyzed with correlation analyses.
Results: Correlation analyses revealed significant associations between accumulating
cSVD burden and decreased performance on all cognitive domains (all p≤0.001). Results
remained significant for information processing speed (r =−0.181, p=0.013) and overall
cognition (r =−0.178, p=0.017), after correction for age and sex. Testing of trend using
linear regression analyses revealed the same results.
Discussion: We tested a new approach to capture total brain damage resulting from cSVD
and found that accumulation of MRI burden of cSVD is associated with decreased per-
formance on tests of information processing speed and overall cognition, implying that
accumulating brain damage is accompanied by worse cognitive functioning.
Keywords: cerebral small vessel disease, cognition, white matter lesions, brain microbleeds, lacunar infarcts,
enlarged perivascular spaces
INTRODUCTION
Cerebral small vessel disease (cSVD) is a disorder affecting the
small perforating vessels in the brain (Pantoni, 2010). cSVD is
a strongly age-related disease and is one of the major causes
of cognitive decline and functional loss in the elderly (Pantoni,
2010). It may result in clinically overt lacunar stroke syndromes,
but also in clinically “silent” manifestations as white matter
lesions (WMLs), asymptomatic lacunar infarcts, brain microb-
leeds (BMBs), and enlarged perivascular spaces (EPVS) (Wardlaw
et al., 2006;Vermeer et al., 2007; Doubal et al., 2010; Pantoni, 2010).
Lesions due to cSVD are thought to disrupt frontal-subcortical
circuits (Schmidtke and Hull, 2005) and consequently impair cog-
nitive functioning. The abovementioned four markers of cSVD
have all been individually linked to cognitive dysfunctioning
(Werring et al., 2004; van den Heuvel et al., 2006; Carey et al., 2008;
Zhu et al., 2010). However, these MRI markers of brain damage
do not occur separately, and studies investigating the effect of the
combined and accumulating presence of these individual markers
on cognition are lacking. Recently, Wardlaw et al. (2013) suggested
to search for methods to assess the total cSVD load on imaging in
order to avoid over-reliance on one feature only.
Some studies focused on the combination of lacunar infarcts
and WMLs (Baune et al., 2009; Jokinen et al., 2011). Baune
et al. (2009) found a combined occurrence of lacunar infarcts
and WMLs in 10% of the population and a significant difference
between those patients with only one lesion type and patients
affected by both on information processing speed and mem-
ory. The authors suggested that the combined occurrence was
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associated with stronger reductions in cognitive function than
each of the two lesion types alone. Additionally, Jokinen et al.
(2011) recently found that the relationship between progression
of WMLs and new lacunes with cognitive decline was additive, but
not synergistic.
No data are available on the clinical consequences of the total
burden of “silent” cSVD on brain MRI, expressed by the co-
occurrence of all four different markers of cSVD. The aim of this
study therefore was to try a new method to capture the total brain
damage caused by cSVD and investigate whether an accumulation
of MRI markers of cSVD was associated with a decreased perfor-
mance on cognitive function. We investigated this in patients at
risk for silent cSVD, most probably due to hypertension-related
occlusive arteriolosclerosis: patients with lacunar (small vessel)
stroke and essential hypertensive patients.
MATERIALS AND METHODS
PARTICIPANTS
Patients included in this study participated in two larger studies;
the hypertensive patients in a longitudinal study on brain dam-
age in hypertension (HYBRiD) (Henskens et al., 2009), whereas
the lacunar stroke patients participated in a study on cognitive
function after lacunar stroke.
Hypertensive patients were referred to our hypertension outpa-
tient clinic of the Department of Internal Medicine of the Maas-
tricht University Medical Center. Of 218 patients included, 112
patients completed a brain MRI and extensive neuropsychologi-
cal assessment for this cross-sectional study. Exclusion criteria at
baseline were a history of symptomatic cardio- or cerebro-vascular
disease or contraindications for MRI.
Of 208 first-ever lacunar stroke patients presenting at the Neu-
rology Department of the Maastricht University Medical Centre
between February 2009 and July 2012, we consecutively included
77 patients. Lacunar stroke was defined as an acute stroke syn-
drome with a small (<20 mm) ischemic lesion on acute brain MR
in the brain stem, basal ganglia, or internal capsule, compatible
with the occlusion of a single perforating small artery. If no such
lesion was visible, we used established clinical criteria for lacunar
stroke (de Jong et al., 2002). Patients with severe co-morbidity,
either neurological or psychiatric, were excluded. Furthermore,
patients without MRI or with possible other causes than cSVD
(cardiac embolic source, cerebral large vessel disease, or carotid
stenosis), were also excluded. Patients underwent neuropsycho-
logical assessment at 3 months after stroke to exclude acute phase
effects.
The presence of vascular risk factors was recorded for all
patients: hypertension, diabetes mellitus, hypercholesterolemia,
and smoking. Data of vascular risk factors was missing for four
hypertensive patients.
Both studies were approved by the Medical Ethics Committee
of the Maastricht University Medical Centre and all participants
gave written informed consent.
BRAIN MAGNETIC RESONANCE IMAGING
MRI of the brain (1.5 or 3 T) was performed to obtain axial
T2-weighted, fluid-attenuated inversion recovery (FLAIR) and
T2*-weighted gradient echo images. Images were independently
rated by two vascular neurologists (Julie Staals and Robert J.
van Oostenbrugge) for the presence of asymptomatic lacunar
infarcts, WMLs, BMBs, and EPVS for the first 137 patients. Kappas
appeared to be satisfactory and the remaining images were rated
by one vascular neurologist only. In case of disagreement or doubt,
lesions were ascertained by consensus. Kappa’s for the presence of
asymptomatic lacunar infarcts and deep BMBs were 0.62 and 0.63,
respectively. Weighted kappa’s for dWMLs and EPVS in the basal
ganglia were 0.77 and 0.69, respectively.
TOTAL BURDEN OF cSVD
We created an ordinal scale representing the total burden of cSVD,
expressed by the co-occurrence of the different MRI markers. The
presence of each of the four MRI markers for cSVD mentioned
above (asymptomatic lacunar infarcts, WMLs, BMBs, and EPVS),
was awarded with one point, resulting in a minimum of 0 and a
maximum of 4.
Asymptomatic lacunar infarcts
We identified asymptomatic lacunar infarcts as sharply demar-
cated hyperintense lesions <20 mm on T2-weighted images with
corresponding hypointense lesions with a hyperintense rim on
FLAIR. In lacunar stroke patients, the lesion could not be compat-
ible with the clinical stroke. One point was awarded when one or
more asymptomatic lacunar infarcts were present.
White matter lesions
White matter lesions were graded according to Fazekas’ scale
(Fazekas et al., 1987). One point was awarded in case of periven-
tricular WMLs Fazekas score 3 (irregular hyperintensities extend-
ing into the deep white matter), and/or in case of deep WMLs
Fazekas score 2 or 3 (confluent white matter hyperintensities).
We used the Fazekas scores because they are histopathologically
related to cSVD (Fazekas et al., 1993).
Brain microbleeds
Brain microbleeds were defined as punctate (<10 mm) homoge-
neous foci of low signal intensity on T2*-weighted images. Sym-
metrical hypointensities in the globi pallidi were disregarded, since
these most likely represent calcification. Since it was suggested
that specifically deep BMBs (defined as basal ganglia, thalamus,
and internal, external, and extreme capsule) are related to cSVD
(Vernooij et al., 2008), one point was awarded only in case of the
presence of one or more deep BMBs.
Enlarged perivascular spaces
Enlarged perivascular spaces were defined as round, oval, or linear
shaped lesions with a smooth margin, absence of mass effect and
with signal intensity equal to cerebrospinal fluid on T2-weighted
images and (if visible) hypointense on FLAIR images without
hyperintense rim to distinguish them from old lacunar infarcts
(Bokura et al., 1998). Since EPVS at the level of the basal ganglia are
specifically related to cSVD (Doubal et al., 2010), EPVS at this level
were scored, on one slice and at one side in the most affected hemi-
sphere only. The quantity of EPVS were rated as follows: category
1=<10 EPVS, category 2= 10–25 EPVS, and category 3=>25
EPVS. One point was awarded in case of moderate (category 2) to
extensive (category 3) EPVS.
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ASSESSMENT OF COGNITIVE FUNCTION
Cognitive function was assessed by one trained neuropsycholo-
gist (MH) during a 2-h session. The test battery included the Rey
Auditory Verbal Learning Test (RAVLT) (Brand and Jolles, 1985),
Stroop Color Word Test (SCWT) (Golden, 1978), Trail making
Test A and B (TMT) (Reitan, 1956), category and letter fluency
(Luteyn, 1966; Lezak et al., 2004), and the following subtests of the
Wechsler Adult Intelligence Scale III (WAIS III) (Wechsler, 2001),
Symbol Substitution, Digit span, and Letter Number Sequencing.
For the SCWT and TMT, interference scores were computed. Inter-
ference score SCWT= time on card 3−Mean (card 1+ card 2).
Interference score TMT= time card B− time card A.
We compared performances on different cognitive domains by
using Z standard scores. A Z -score was calculated for each test
score separately. For each domain we computed compound scores.
Memory domain= (Z /RAVLT immediate recall+Z /RAVLT
delayed recall+Z /RAVLT word recognition+Z /digit span
forward)/4; Executive functions domain= (Z /SCWT inter-
ference+Z /TMT interference+Z /category fluency+Z /letter
fluency+Z /digit span backward+Z /letter number sequenc-
ing)/6; Information processing speed= (Z /symbol substitu-
tion+Z /TMT A+Z /mean of Stroop card 1 and 2)/3. A com-
pound score for overall cognitive function was calculated as
the mean score of the three compound scores. Z -scores of
tests with higher scores representing worse performance were
inverted before computing the compound scores. Compound
scores for memory, executive function, information process-
ing speed, and overall cognition were missing for five, five,
one, and nine patients, respectively. Therefore, analyses on
these variables were performed with a different number of
subjects.
STATISTICAL ANALYSIS
In the unadjusted analysis, we associated cognitive compound
scores (memory, information processing speed, executive func-
tion, and overall cognition) with the levels of the total burden
of cSVD, using bivariate correlation analyses. All analyses were
done using the non-parametric spearman’s Rho due to the ordi-
nal nature of the total cSVD burden quantification. In order to
adjust for possible confounders, such as age and sex, we per-
formed linear regression analyses with the confounding factors
as independent and the cognitive domain as dependent variable.
Residuals were saved and used in the non-parametric correlation
analyses.
For testing of trend, the ordinal scale expressing the total
burden of cSVD was considered as a continuous variable in a lin-
ear regression model with cognition as dependent variable, with
adjustments for age and sex.
All analyses were performed using IBM SPSS statistics 18.0.
RESULTS
In total, 189 patients (112 hypertensive patients and 77 lacu-
nar stroke patients) were included and 217 (86 hypertensive
patients and 131 lacunar stroke patients) excluded. Excluded
patients were older than those who were included (66.4± 15.0
vs. 59.9± 12.7 years, p< 0.001), but did not differ regarding sex
(p= 0.095). Reasons for exclusion were: not interested (47.0%),
atrial fibrillation (16.1%), cerebro-vascular accident or transient
ischemic attack before inclusion (4.1%; for hypertensive patients
only), pre-existent cognitive problems (3.2%), carotid stenosis
(3.2%), contraindications for MRI (2.8%), death (1.8%), or other
reasons (21.7%). Patient characteristics as well as the distribution
of cSVD categories of the included lacunar stroke and hypertensive
patients are shown in Table 1.
TOTAL BURDEN OF cSVD
Ninety-one patients (48.1%) had none of the silent MRI markers
for cSVD, and five patients (2.6%) presented with all four mark-
ers. For patients with one, two, or three markers, the presence
of the cSVD markers within each category is shown in Table 2
and the distribution of combinations is shown in Figure 1. Age
increased significantly with increasing categories (0–4) of total
burden of cSVD (54.4± 12.4; 60.6± 9.3; 65.5± 11.2; 70.6± 9.1;
77.8± 6.0 years, respectively, p< 0.001). Sex was not significantly
different across the categories.
ASSOCIATION WITH COGNITIVE FUNCTION
Figure 2 shows the mean Z -scores on each of the cogni-
tive domains, stratified by cSVD category. Correlation analyses
revealed significant negative correlations between cSVD category
and all cognitive domains (all p< 0.001). When we adjusted
Table 1 | Patient characteristics and frequencies of cSVD extent.
All cSVD
patients
(n=189)
Lacunar stroke
patients (n=77)
Hypertensive
patients
(n=112)
Age, mean years (SD) 63.1 (14.3) 65.0 (12.0) 56.5 (12.1)
Male sex 108 (57.1) 43 (55.8) 65 (58.0)
Hypertension 159 (84.1) 47 (61.0) 112 (100.0)
Diabetes 9 (4.7) 7 (9.1) 2 (1.8)
Hypercholesterolemia 95 (51.6) 53 (69.7) 42 (38.9)
Current smoking 40 (21.3) 24 (31.2) 16 (14.4)
cSVD category
0 91 (48.1) 23 (29.9) 68 (60.7)
1 41 (21.7) 15 (19.5) 26 (23.2)
2 33 (17.5) 21 (27.3) 12 (10.7)
3 19 (10.1) 13 (16.9) 6 (5.4)
4 5 (2.6) 5 (6.5) 0 (0.0)
Data are shown in frequencies (%), except where reported otherwise.
Table 2 | Distribution of cSVD manifestations according to total
burden of cSVD.
Category 1
(n=41)
Category 2
(n=33)
Category 3
(n=19)
Asymptomatic infarct 18 (43.9) 24 (72.7) 15 (78.9)
White matter lesions 3 (7.3) 12 (36.4) 14 (73.3)
Brain microbleeds 7 (17.1) 6 (18.2) 11 (57.9)
Enlarged perivascular spaces 13 (31.7) 24 (72.7) 17 (89.5)
Data are shown in frequencies (%).
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FIGURE 1 | Distribution of (combinations of) cSVD manifestations
according to total burden of cSVD. (A) Percentages of each lesion when
one lesion is present. (B) Percentages of the combinations when two lesions
are present. (C) Percentages of the combinations when three lesions are
present. LAC, asymptomatic lacunar infarcts; WML, white matter lesions;
BMB, brain microbleeds; EPVS, enlarged perivascular spaces.
for age and sex in the analyses, results remained significant for
information processing speed and overall cognition (Table 3).
For the test of trend using linear regression analyses we
found significant negative associations between cSVD cate-
gory and all cognitive domains. When we adjusted for age
and sex, results remained significant for information process-
ing speed (β=−0.154; 95% CI=−0.254 to −0.054, p= 0.003)
and overall cognition (β=−0.099; 95% CI=−0.183 to −0.016,
p= 0.019). Results for executive function were borderline signifi-
cant (β=−0.087; 95% CI=−0.181 to 0.007, p= 0.070).
Frequencies for the different combinations within each cate-
gory were too small in order to compare cognitive function.
DISCUSSION
We demonstrated that accumulation of MRI markers of cSVD,
expressed by the co-occurrence of these markers, is associated with
decreased performance on all cognitive domains. After adjust-
ments for age and sex, results remained significant for information
processing speed and overall cognition.
The present literature mainly focused on the effect of single
markers of cSVD on cognitive function, but no study has ever
investigated the effect of the total burden of cSVD, expressed by
all four MRI features that are now recognized as markers of cSVD,
on cognitive function before. Our results extend the results of
Baune et al. (2009) who found that the occurrence of two differ-
ent MRI features (WMLs and lacunar infarcts) was associated with
stronger reductions of cognitive function than the occurrence of
one lesion only.
A recent study (Smallwood et al., 2012) proposed a pathol-
ogy score for extent of cSVD and showed a relation between
severity of cSVD pathology and cognitive impairment. From
our results, it can be speculated that the co-occurrence of
several different lesions represents more severe and extensive
cSVD with more subcortical microstructural brain damage,
resulting in cognitive dysfunction. However, the cross-sectional
nature of our study prevents statements about causality. Lon-
gitudinal studies following increase of MRI markers and cog-
nitive decline over time are needed in order to confirm a
causal relationship between total burden of cSVD and cognitive
function.
We do not know whether one silent MRI marker has more
effect on cognition than the other marker. Regarding different
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FIGURE 2 | Mean Z -scores on each of the cognitive domains, stratified by cSVD category. cSVD, cerebral small vessel disease.
Table 3 | Correlation analyses between total burden of cSVD and
cognitive function.
Model 1
correlation
coefficient
Model 2
correlation
coefficient
Memory −0.333** −0.108
Executive function −0.312** −0.129
Information processing speed −0.438** −0.181*
Overall cognition −0.407** −0.178*
Model 1: bivariate correlation analyses. Model 2: correlation analyses with adjust-
ment for age and sex.
*p< 0.05.
**p<0.001.
combinations of cSVD markers, we were not able to compare
cognitive function within each category of cSVD due to low
frequencies. When higher numbers of patients can be included
in future studies, it would be interesting to study whether one
marker has a different effect weight than the other, or whether spe-
cific combinations of cSVD markers are associated with decreased
cognitive performance more than others.
The major strength of this study is the extensive neuropsycho-
logical assessment which made it possible to evaluate cognitive
function in several domains. The fact that the domain of informa-
tion processing speed was most strongly and significantly related
to cSVD, is in line with other studies that report information pro-
cessing speed as one of the most affected cognitive domains in
patients with cSVD (Prins et al., 2005).
Limitations of our study are mainly situated in the construction
of the cSVD scale. We did not take into account all aspects, like
the extent, location, or progression of each cSVD marker. Based
on previous literature of cSVD (Vernooij et al., 2008; Doubal et al.,
2010), we rated only deep BMBs and basal ganglia EPVS. However,
we did not integrate for example the number of asymptomatic
lacunar infarcts or number of BMBs, although it was recently
found that a higher number of infarcts (Aggarwal et al., 2012)
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or BMBs (Poels et al., 2012) is associated with decreased cog-
nitive performance. We dichotomized each marker which might
lead to loss of power and information, and cut-off points may be
arbitrary, although chosen with arguments. Nevertheless, accord-
ing to a recent review by Wardlaw et al. (2013) on neuroimaging
aspects of cSVD, approaches that try to capture the total cSVD
burden on MRI are needed and we made a first attempt that is
now open for further discussion, testing, and refinement. Another
limitation is the variable MRI field strength that was used in our
population. It was found that more BMBs can be detected at 3 T
than at 1.5 T (Stehling et al., 2008) and this might have led to
overrating in some of our patients. However, analyses with a cor-
rection for field strength did not change our results (results not
shown). A final but important limitation is the mixed popula-
tion of lacunar stroke and hypertensive patients, although both
groups are at considerable risk of silent cSVD. The symptomatic
stroke could have had a negative impact on cognitive function
although we feel that the background silent cSVD is a more impor-
tant determinant of cognitive function (Gottesman and Hillis,
2010).
In conclusion, we tested a new approach to capture total brain
damage resulting from cSVD. We found that accumulation of MRI
markers of cSVD is associated with decreased performance on tests
of information processing speed and overall cognition, imply-
ing that accumulating brain damage is accompanied by worse
cognitive functioning. We suggest further longitudinal studies in
more homogeneous patient samples, and studies including more
patients with higher prevalence of cSVD features in order to refine
our cSVD scale and to be able to investigate whether specific com-
binations of cSVD markers are associated with decreased cognitive
performance.
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